PPIL5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.972200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.263200E-01
Normal-vs-Stage2
6.433400E-01
Normal-vs-Stage3
4.181000E-01
Normal-vs-Stage4
9.370000E-01
Stage1-vs-Stage2
4.293600E-01
Stage1-vs-Stage3
3.881000E-01
Stage1-vs-Stage4
9.818000E-01
Stage2-vs-Stage3
1.026400E-01
Stage2-vs-Stage4
5.305600E-01
Stage3-vs-Stage4
3.616000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.613000E-01
Normal-vs-AfricanAmerican
8.505400E-01
Normal-vs-Asian
9.990800E-01
Caucasian-vs-AfricanAmerican
3.511200E-01
Caucasian-vs-Asian
4.101200E-01
AfricanAmerican-vs-Asian
7.831200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.901000E-01
Normal-vs-Female
7.097400E-01
Male-vs-Female
9.100000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.099000E-01
Normal-vs-Age(41-60Yrs)
5.758000E-01
Normal-vs-Age(61-80Yrs)
8.365600E-01
Normal-vs-Age(81-100Yrs)
2.292400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.088400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.932000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.778600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.613770E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.866000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.960300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.478200E-01
Normal-vs-Daily Drinker
6.673800E-01
Normal-vs-Weekly Drinker
7.685600E-01
Normal-vs-Occasional Drinker
6.894200E-01
Normal-vs-Social Drinker
8.081400E-01
Non Drinker-vs-Daily Drinker
4.382000E-01
Non Drinker-vs-Weekly Drinker
5.870000E-01
Non Drinker-vs-Occasional Drinker
4.439000E-01
Non Drinker-vs-Social Drinker
7.692800E-01
Daily Drinker-vs-Weekly Drinker
8.995600E-01
Daily Drinker-vs-Occasional Drinker
9.345400E-01
Daily Drinker-vs-Social Drinker
6.726000E-01
Weekly Drinker-vs-Occasional Drinker
9.406800E-01
Weekly Drinker-vs-Social Drinker
7.119200E-01
Occasional Drinker-vs-Social Drinker
6.597200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.306600E-01
Normal-vs-Grade 2
7.771800E-01
Normal-vs-Grade 3
7.887800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.385160E-01
Grade 1-vs-Grade 3
1.016180E-01
Grade 1-vs-Grade 4
7.306600E-01
Grade 2-vs-Grade 3
6.623200E-01
Grade 2-vs-Grade 4
7.771800E-01
Grade 3-vs-Grade 4
7.887800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.960800E-01
Normal-vs-NonDiabetic
6.967400E-01
Diabetic-vs-NonDiabetic
6.083200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.069200E-01
Normal-vs-NoPancreatitis
6.881200E-01
Pancreatitis-vs-NoPancreatitis
3.261800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.866000E-01
Normal-vs-N1
6.694000E-01
N0-vs-N1
9.029200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.832200E-01
Normal-vs-TP53-NonMutant
9.427000E-01
TP53-Mutant-vs-TP53-NonMutant
8.350400E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
